Ptc Therapeutics (PTCT) Net Income Growth (5y) (2017 - 2026)
Ptc Therapeutics (PTCT) Net Income Growth (5y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,200.25 Bn | 66,199.96 Bn | - |
| 2 | Nanobiotix | 1,908.00 Bn | 1,907.94 Bn | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - |
| 4 | BeOne Medicines | 471.75 Bn | 466.96 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.94 Bn | 114.69 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.87 Bn | 61.12 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.43 Bn | 62.43 Bn | - |
| 8 | Argenx Se | 55.86 Bn | 50.68 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.49 Bn | 34.48 Bn | 959.66 Mn |
| 10 | Ptc Therapeutics | 6.27 Bn | 4.38 Bn | 244.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 53.46% |
| Dec 31, 2025 | -18.19% |
| Sep 30, 2025 | 17.38% |
| Jun 30, 2025 | 18.60% |
| Mar 31, 2025 | 57.49% |
| Dec 31, 2024 | 25.31% |
| Sep 30, 2024 | -12.19% |
| Jun 30, 2024 | -18.87% |
| Mar 31, 2024 | -4.89% |
| Dec 31, 2023 | -42.73% |
| Sep 30, 2023 | -21.14% |
| Jun 30, 2023 | -83.65% |
| Mar 31, 2023 | -48.47% |
| Dec 31, 2022 | -177.71% |
| Sep 30, 2022 | -26.51% |
| Jun 30, 2022 | -54.15% |
| Mar 31, 2022 | -34.25% |
| Dec 31, 2021 | -39.00% |
| Sep 30, 2021 | -30.60% |
| Jun 30, 2021 | -24.92% |